C2 skeletal myoblast survival, death, proliferation and differentiation: Regulation by adra1d

Cellular Physiology and Biochemistry

Volumn 25, Issue 2-3, 2010, Pages 253-262

  Saini, Amarjit ^a   Al Shanti, Nasser ^a   Stewart, Claire ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Adra1d; Apoptosis; IGF I; MAP kinase; Myoblasts; TNF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN ADRA1D; SMALL INTERFERING RNA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 76249102955     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276559     Document Type: Article

References (41)

1. Saini A, Al-Shanti N, Faulkner SH, Stewart CE: Pro-and anti-apoptotic roles for igf-i in tnf-alpha-induced apoptosis: A map kinase mediated mechanism. Growth Factors 2008;26:239-253.
2. Morley JE, Baumgartner RN: Cytokine-related aging process. J Gerontol A Biol Sci Med Sci 2004;59:M924-929.
3. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 2002;2:862-871.
4. Walsmith J, Roubenoff R: Cachexia in rheumatoid arthritis. Int J Cardiol 2002;85:89-99.
5. Glass DJ: Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003;5:87-90.
6. Argiles JM, Lopez-Soriano FJ: The role of cytokines in cancer cachexia. Med Res Rev 1999;19:223-248.
7. Foulstone EJ, Meadows KA, Holly JM, Stewart CE: Insulin-like growth factors (igf-i and igf-ii) inhibit c2 skeletal myoblast differentiation and enhance tnf alpha-induced apoptosis. J Cell Physiol 2001;189:207-215.
8. Meadows KA, Holly JM, Stewart CE: Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol 2000;183:330-337.
9. Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS: In vivo satellite cell activation via myf5 and myod in regenerating mouse skeletal muscle. J Cell Sci 1999;112:2895-2901.
10. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS: "Spontaneous" Differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-ii. J Biol Chem 1991;266:15917-15923.
11. Stewart CE, Rotwein P: Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol Rev 1996;76:1005-1026.
12. Li Y, Jiang B, Ensign W Y, Vogt PK, Han J: Myogenic differentiation requires signalling through both phosphati-dylinositol 3-kinase and p38 map kinase. Cell Signal 2000;12:751-757.
13. Al-Shanti N, Stewart CE: Pd98059 enhances c2 myoblast differentiation through p38 mapk activation: A novel role for pd98059. J Endocrinol 2008;198:243-252.
14. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869.
15. Foulstone EJ, Huser C, Crown AL, Holly JM, Stewart CE: Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: Roles of igf-i and tnfalpha. Exp Cell Res 2004;294:223-235.
16. Hubbard KB, Hepler JR: Cell signalling diversity of the gqalpha family of heterotrimeric g proteins. Cell Signal 2006;18:135-150.
17. Offermanns S: G-proteins as transducers in transmembrane signalling. Prog Biophys Mol Biol 2003;83:101-130.
18. Exton JH: Regulation of phosphoino-sitide phospholipases by hormones, neurotransmitters, and other agonists linked to g proteins. Annu Rev Pharmacol Toxicol 1996;36:481-509.
19. Wu D, Katz A, Lee CH, Simon MI: Activation of phospholipase c by alpha 1-adrenergic receptors is mediated by the alpha subunits of gq family. J Biol Chem 1992;267:25798-25802.
20. Fain JN, Garcia-Sainz JA: Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines. Life Sci 1980;26:1183-1194.
21. Theroux TL, Esbenshade TA, Peavy RD, Minneman KP: Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: Titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 1996;50:1376-1387.
22. Strosberg AD: Structure, function, and regulation of adrenergic receptors. Protein Sci 1993;2:1198-1209.
23. Xing M, Insel PA: Protein kinase c-dependent activation of cytosolic phospholipase a2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in madin-darby canine kidney cells. J Clin Invest 1996;97:1302-1310.
24. Balboa MA, Insel PA: Stimulation of phospholipase d via alpha1-adrenergic receptors in madin-darby canine kidney cells is independent of pkcalpha and -epsilon activation. Molecular pharmacology 1998;53:221-227.
25. Parmentier JH, Ahmed A, Ruan Y, Gandhi GK, Saeed AE, Malik KU: Calcium and protein kinase c (pkc)-related kinase mediate alpha 1a-adrenergic receptor-stimulated activation of phospholipase d in rat-1 cells, independent of pkc. J Pharmacol Exp Ther 2002;303:1206-1215.
26. Ruan Y, Kan H, Parmentier JH, Fatima S, Allen LF, Malik KU: Alpha-1a adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase d in rat-1 fibroblasts: Inhibition by protein kinase a. J Pharmacol Exp Ther 1998;284:576-585.
27. Morgan NG, Charest R, Blackmore PF, Exton JH: Potentiation of alpha 1-adrenergic responses in rat liver by a camp-dependent mechanism. Proc Natl Acad Sci USA 1984;81:4208-4212.
28. Yaffe D, Saxel O: Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977;270:725-727.
29. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide rnas mediate rna interference in cultured mammalian cells. Nature 2001;411:494-498.
30. Elbashir SM, Lendeckel W, Tuschl T: Rna interference is mediated by 21-and 22-nucleotide rnas. Genes Dev 2001;15:188-200. (Pubitemid 32107664)
31. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T: Functional anatomy of sirnas for mediating efficient rnai in drosophila melanogaster embryo lysate. Embo J 2001;20:6877-6888.
32. Tuschl T: Rna interference and small interfering rnas. Chembiochem 2001;2:239-245.
33. Stewart CE, Newcomb PV, Savage PB, Dickens M, Tavare J, Holly JM: Increased, not decreased activation of the insulinlike growth factor (igf) receptor signalling pathway during ceramide-induced apoptosis. Growth Horm IGF Res 1999;9:131-142.
34. Zhao SP, Zeng LH: Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. International journal of cardiology 1997;58:257-261.
35. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB: Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated nf-kappab activation in response to tumor necrosis factor alpha. Faseb J 1998;12:871-880.
36. Hoshino E, Pichard C, Greenwood CE, Kuo GC, Cameron RG, Kurian R, Kearns JP, Allard JP, Jeejeebhoy KN: Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol 1991;260:E27-36.
37. Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC: Tnf-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 2002;282:E336-347.
38. Broussard SR, McCusker RH, Novakofski JE, Strle K, Shen WH, Johnson RW, Freund GG, Dantzer R, Kelley KW: Cytokine-hormone interactions: Tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor i receptor in myoblasts. Endocrinology 2003;144:2988-2996.
39. Strle K, Broussard SR, McCusker RH, Shen WH, Johnson RW, Freund GG, Dantzer R, Kelley KW: Proinflammatory cytokine impairment of insulinlike growth factor i-induced protein synthesis in skeletal muscle myoblasts requires ceramide. Endocrinology 2004;145:4592-4602.
40. Bommakanti RK, Vinayak S, Simonds WF: Dual regulation of akt/protein kinase b by heterotrimeric g protein subunits. J Biol Chem 2000;275:38870-38876.
41. Glass DJ: Molecular mechanisms modulating muscle mass. Trends Mol Med 2003;9:344-350.